Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1/2 1

Status

Completed 21Recruiting 6Unknown 5Withdrawn 4Terminated 3Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 3INDUSTRY 3NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1

Conditions

Sarcoma 1Recurrence 1Ovarian Neoplasms 1Liposarcoma 1Leiomyosarcoma 1Ichthyosis, X-Linked 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Trabectedin × Clear all
NCT03164980 2025-03-20

COMPASS

North Eastern German Society of Gynaecological Oncology

Phase 4 Terminated
89 enrolled 20 charts
Gynecologic

Ovarian Neoplasms, Recurrence

NCT03074318 2022-04-29

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
35 enrolled 21 charts
Sarcoma

Leiomyosarcoma, Liposarcoma

NCT01104298 2015-10-27

Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Terminated
115 enrolled
Sarcoma

Sarcoma, Ichthyosis, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡